Amy Lowichik,
MD, PhD

No Rating Available?
0
out of
5
Patient Rating
In order to provide our patients and visitors with the most accurate and useful information, we only post physician satisfaction data when a physician has received a minimum of 30 returned surveys. For this provider, we have not yet received the
minimum.
Languages Spoken: English
Dr. Lowichik has been practicing pediatric pathology for over 20 years, with subspecialty interest in pediatric gastrointestinal and hepatic medical disease.
Clinical Locations
Primary Children's Hospital
Pathology801-662-2150
Fax: (801) 662-2165
Specialties
Board Certification and Academic Information
Academic Departments | Pathology
-
Professor (Clinical) |
Academic Divisions | Pediatric Pathology |
Board Certification | American Board of Pathology (Clinical Path) American Board of Pathology (Sub: Anatomic Path) American Board of Pathology (Sub: Pediatric Pathology) |
Dr. Lowichik has been practicing pediatric pathology for over 20 years, with subspecialty interest in pediatric gastrointestinal and hepatic medical disease.
Academic Locations
Board Certification and Academic Information
Academic Departments | Pathology
-
Professor (Clinical) |
Academic Divisions | Pediatric Pathology |
Board Certification | American Board of Pathology (Clinical Path) American Board of Pathology (Sub: Anatomic Path) American Board of Pathology (Sub: Pediatric Pathology) |
Education History
Residency | University of Texas Southwestern Medical School Clinical Pathology Resident, 1996 |
Fellowship | University of Texas Southwestern Medical School Pediatric Pathology Fellow, 1995 |
Residency | University of Texas Southwestern Medical School Anatomic Pathology Resident, 1993 |
Residency | Children's Medical Center of Dallas Pediatrics Resident, 1991 |
Internship | Children's Medical Center of Dallas Pediatrics Intern, 1989 |
Doctoral Training | Tulane University Zoology & Microbiology Ph.D., 1988 |
Professional Medical | University of Michigan Medicine M.D., 1983 |
Undergraduate | University of Michigan B.S., 1983 |
Selected Publications - Journal Articles
Journal Article
- Lozano Chinga M, Afify Z, Lowichik A, Grinsell MM, Seamon M, Meznarich JA (2022). Female adolescent with recurrent anemia and thrombocytopenia: Questions. Pediatr Nephrol.
- Lozano Chinga M, Afify Z, Lowichik A, Grinsell MM, Seamon M, Meznarich JA (2022). Female adolescent with recurrent anemia and thrombocytopenia: Answers. Pediatr Nephrol.
- Lucas CG, Abdullaev Z, Bruggers CS, Mirchia K, Whipple NS, Alashari MM, Lowichik A, Cheshier S, Phillips JJ, Devine P, Solomon DA, Quezado M, Aldape KD, Perry A (2021). Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma. Acta Neuropathol, 143(2), 283-286.
- Lucas CH, Abdullaev Z, Bruggers CS, Mirchia K, Whipple NS, Alashari MM, Lowichik A, Cheshire S, Phillips JJ, Devine P, Solomon DA, Quezado M, Aldape KD, Perry A (2021). Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma. Acta Neuropathol.
- Teckman J, Rosenthal P, Hawthorne K, Spino C, Bass LM, Murray KF, Kerkar N, Magee JC, Karpen S, Heubi JE, Molleston JP, Squires RH, Kamath BM, Guthery SL, Loomes KM, Sherker AH, Sokol RJ, ChiLDReN Childhood Liver Disease Research Network (2020). Longitudinal Outcomes in Young Patients with Alpha-1-Antitrypsin Deficiency with Native Liver Reveal that Neonatal Cholestasis is a Poor Predictor of Future Portal Hypertension. J Pediatr, 227, 81-86.e4.
- McClain A, OGorman M, Barbagelata C, Patel R, Lowichik A, Peterson K, Guthery S, Robson J (2019). Adherence to Biopsy and Follow-Up Guidelines in a Population-Based Cohort of Children With Eosinophilic Esophagitis. Clin Gastroenterol Hepatol, 18(11), 2620-2622.
- Jaramillo C, Guthery SL, Lowichik A, Stoddard G, Kim T, Li Y, Jensen MK (2019). Quantitative Liver Fibrosis Using Collagen Hybridizing Peptide to Predict Native Liver Survival in Biliary Atresia: A Pilot Study. J Pediatr Gastroenterol Nutr, 70(1), 87-92.